Left posterior approach to the superior mesenteric vascular pedicle in pancreaticoduodenectomy for cancer of the pancreatic head

Journal of the Pancreas

Volumn 12, Issue 3, 2011, Pages 220-229

  Kurosaki, Isao ^a   Minagawa, Masahiro ^a   Takano, Kabuto ^a   Takizawa, Kazuyasu ^a   Hatakeyama, Katsuyoshi ^a  

^a NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

Author keywords

Adjuvant; Chemotherapy; Dissection; Mesenteric Artery; Operative; Pancreatic Neoplasms; Pancreaticoduodenectomy; Superior; Surgical Procedures

Indexed keywords

FLUOROURACIL; GEMCITABINE;

ABDOMINAL BLEEDING; ADULT; AGED; ANASTOMOSIS LEAKAGE; ARTICLE; CANCER ADJUVANT THERAPY; CANCER SURVIVAL; CHYLOUS ASCITES; CLINICAL ARTICLE; CONTROLLED STUDY; DIARRHEA; FEMALE; GASTRIC DYSMOTILITY; HUMAN; INTERMETHOD COMPARISON; MALE; OUTCOME ASSESSMENT; PANCREAS CANCER; PANCREAS FISTULA; PANCREATICODUODENECTOMY; PERITONITIS; SUPERIOR MESENTERIC ARTERY; SUPERIOR MESENTERIC VEIN; SURGICAL APPROACH; SURGICAL TECHNIQUE; SURVIVAL RATE; VASCULAR PEDICLE; WOUND DEHISCENCE;

AGED; AGED, 80 AND OVER; CHEMOTHERAPY, ADJUVANT; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MESENTERIC ARTERY, SUPERIOR; MESENTERIC VEINS; MIDDLE AGED; MODELS, ANATOMIC; PANCREAS; PANCREATIC NEOPLASMS; PANCREATICODUODENECTOMY; POSTOPERATIVE CARE; TREATMENT OUTCOME;

EID: 79957593991     PISSN: 15908577     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Bachellier P, Nakano H, Oussoultzoglou PD, Weber JC, Boudjema K, Wolf PD, Jaeck D. Is pancreaticoduodenectomy with mesentericoportal venous resection safe and worthwhile? Am J Surg. 2001; 182:120-129. [PMID 11574081]
2. Carrère N, Sauvanet A, Goere D, Kianmanesh R, Vullierme MP, Couvelard A, et al. Pancreaticoduodenectomy with mesentericoportal vein resection for adenocarcinoma of the pancreatic head. World J Surg. 2006; 30:1526-1535. [PMID 16855797]
3. Tseng JF, Raut CP, Lee JE, Pisters PW, Vauthey JN, Abdalla EK, et al. Pancreaticoduodenectomy with vascular resection: margin status and survival duration. J Gastrointest Surg 2004; 8:935-949. [PMID 15585381]
4. Pessaux P, Varma D, Arnaud JP. Pancreaticoduodenectomy: superior mesenteric artery first approach. J Gastrointest Surg. 2006; 10:607-611. [PMID 16627229]
5. Nitecki SS, Sarr MG, Colby TV, van Heerden JA. Long-term survival after resection for ductal adenocarcinoma of the pancreas. Is it really improving? Ann Surg. 1995; 221:59-66. [PMID 7826162]
6. Hishinuma S, Ogata Y, Tomikawa M, Ozawa I, Hirabayashi K, Igarashi S. Patterns of recurrence after curative resection of pancreatic cancer, based on autopsy findings. J Gastrointest Surg. 2006; 10:511-518. [PMID 16627216]
7. de Castro SM, Kuhlmann KF, van Heek NT, Busch OR, Offerhaus GJ, van Gulik TM, et al. Recurrent disease after microscopically radical (R0) resection of periampullary adenocarcinoma in patients without adjuvant therapy. J Gastrointest Surg. 2004; 8:775-784. [PMID 15531230]
8. Raut CP, Tseng JF, Sun CC, Wang H, Wolff RA, Crane CH, et al. Impact of resection status on pattern of failure and survival after pancreaticoduodenectomy for pancreatic adenocarcinoma. Ann Surg. 2007; 246:52-60. [PMID 17592291]
9. Kinsella TJ, Seo Y, Willis J, Stellato TA, Siegel CT, Harpp D, et al. The impact of resection margin status and postoperative CA19-9 levels on survival and patterns of recurrence after postoperative highdose radiotherapy with 5-FU-based concurrent chemotherapy for resectable pancreatic cancer. Am J Clin Oncol. 2008; 31:446-453. [PMID 18838880]
10. Kurosaki I, Kawachi Y, Nihei K, Tsuchiya Y, Aono T, Yokoyama N, et al. Liver perfusion chemotherapy with 5-Fluorouracil followed by systemic gemcitabine administration for resected pancreatic cancer: preliminary results of a prospective phase 2 study. Pancreas. 2009; 38:161-167. [PMID 18797423]
11. Farnell MB, Pearson RK, Sarr MG, DiMagno EP, Burgart LJ, Dahl TR, et al. Pancreas Cancer Working Group. A prospective randomized trial comparing standard pancreatoduodenectomy with pancreatoduodenectomy with extended lymphadenectomy in resectable pancreatic head adenocarcinoma. Surgery. 2005; 138:618-28. [PMID 16269290]
12. Pedrazzoli S, DiCarlo V, Dionigi R, Mosca F, Pederzoli P, Pasquali C, et al. Standard versus extended lymphadenectomy associated with pancreatoduodenectomy in the surgical treatment of adenocarcinoma of the head of the pancreas: a multicenter, prospective, randomized study. Lymphadenectomy Study Group. Ann Surg. 1998; 228:508-517. [PMID 9790340]
13. Esposito I, Kleeff J, Bergmann F, Reiser C, Herpel E, Friess H, et al. Most pancreatic cancer resections are R1 resections. Ann Surg Oncol. 2008; 15:1651-1660. [PMID 18351300]
14. Khalifa MA, Maksymov V, Rowsell C. Retroperitoneal margin of the pancreaticoduodenectomy specimen: anatomic mapping for the surgical pathologist. Virchows Arch. 2009; 454:125-131. [PMID 19066952]
15. Sergeant G, Ectors N, Fieuws S, Aerts R, Topal B. Prognostic relevance of extracapsular lymph node involvement in pancreatic ductal adenocarcinoma. Ann Surg Oncol. 2009; 16:3070-3079. [PMID 19649555]
16. Nagai H, Ohki J, Kondo Y, Yasuda T, Kasahara K, Kanazawa K. Pancreatoduodenectomy with preservation of the pylorus and gastroduodenal artery. Ann Surg. 1996; 223:194-198. [PMID 8597514]
17. Noto M, Miwa K, Kitagawa H, Kayahara M, Takamura H, Shimizu K, Ohta T. Pancreas head carcinoma: frequency of invasion to soft tissue adherent to the superior mesenteric artery. Am J Surg Pathol. 2005; 29:1056-1061. [PMID 16006800]
18. Nakao A, Takeda S, Inoue S, Nomoto S, Kanazumi N, Sugimoto H, Fujii T. Indications and techniques of extended resection for pancreatic cancer. World J Surg. 2006; 30:976-982. [PMID 16736324]
19. Dumitrascu T, David L, Popescu I. Posterior versus standard approach in pancreatoduodenectomy: a case-match study. Langenbecks Arch Surg. 2010; 395:677-684. [PMID 19418065]
20. Varty PP, Yamamoto H, Farges O, Belghiti J, Sauvanet A. Early retropancreatic dissection during pancreaticoduodenectomy. Am J Surg. 2005; 189:488-491. [PMID 15820467]
21. Traverso LW. Pancreatic cancer: surgery alone is not sufficient. Surg Endosc. 2006; 20 Suppl 2:S446-449. [PMID 16557419]
22. Capussotti L, Massucco P, Ribero D, Viganò L, Muratore A, Calgaro M. Extended lymphadenectomy and vein resection for pancreatic head cancer: outcomes and implications for therapy. Arch Surg. 2003; 138:1316-1322. [PMID 14662531]
23. Henne-Bruns D, Vogel I, Lüttges J, Klöppel G, Kremer B. Surgery for ductal adenocarcinoma of the pancreatic head: staging, complications, and survival after regional versus extended lymphadenectomy. World J Surg. 2000; 24:595-601. [PMID 10787083]
24. Yeo CJ, Cameron JL, Sohn TA, Coleman J, Sauter PK, Hruban RH, et al. Pancreaticoduodenectomy with or without extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma: comparison of morbidity and mortality and short-term outcome. Ann Surg. 1999; 229:613-622. [PMID 10235519]
25. Asiyanbola B, Gleisner A, Herman JM, Choti MA, Wolfgang CL, Swartz M, et al. Determining pattern of recurrence following pancreaticoduodenectomy and adjuvant 5-flurouracil-based chemoradiation therapy: effect of number of metastatic lymph nodes and lymph node ratio. J Gastrointest Surg. 2009; 13:752-759. [PMID 19089517]
26. Hirota M, Shimada S, Yamamoto K, Tanaka E, Sugita H, Egami H, Ogawa M. Pancreatectomy using the no-touch isolation technique followed by extensive intraoperative peritoneal lavage to prevent cancer cell dissemination: a pilot study. JOP. J Pancreas 2005; 6:143-151. [PMID 15767730]
27. Horiguchi A, Ishihara S, Ito M, Nagata H, Shimizu T, Furusawa K, et al. Pancreatoduodenectomy in which dissection of the efferent arteries of the head of the pancreas is performed first. J Hepatobiliary Pancreat Surg. 2007; 14:575-578. [PMID 18040623]
28. Oettle H, Post S, Neuhaus P, Gellert K, Langrehr J, Ridwelski K, et al. Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial. JAMA 2007;297:267-77 [PMID 17227978]